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CEREBRAL AMYLOID ANGIOPATHY AND
ICH – A SYSTEMATIC REVIEW
MOHAMMED F REHMAN, DO
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Objectives
• Definition of CAA as a disease

• Key clinical/MRI signatures
• Implications for treatments, BP, OAC etc.

• latest developments, current trends – No RCTs to
date.

Key Take Home Message
•MRI is crucial when CAA is suspected

– For diagnosis
– For prognosis
• Cortical superficial siderosis – driver of
bleeding
• CAA is not only about hemorrhage –
ischemic Lesions, encephalopathies,
inflammation/angiitis.

What is CAA
Operational definitions – 3 intersecting levels:
1. Neuropathological level
2. Key clinical presentations / Boston criteria
❑ Spontaneous lobar ICH (10-30% of all ICH)
❑ CAA non-ICH syndromes
“Amyloid spells”, acute cSAH
dementia
CAA related vaculopathies
3. MRI markers and other biomarkers
❑ Early diagnosis – incidental finding

Cerebral Amyloid Angiopathy
• Disease of the elderly
(~50% of ICH in >80)
• Deposition of amyloid
protein in
media/adventitia of small
cortical arteries,
arterioles and capillaries
• Cortex and cerebellum

What is CAA?
Pathologically common, clinically relevant
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CAA pathophysiology: complex,
poorly understood
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Figure 5 Suggested heuristic schematic of the possible different
phenotypes of CAA and directions in the expression of ...

Brain, Volume 140, Issue 7, July 2017, Pages 1829–1850, https://doi.org/10.1093/brain/awx047
The content of this slide may be subject to copyright: please see the slide notes for details.
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Heriditary CAA Spectrum
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CAA diagnosis – Boston Criteria
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A schematic representation of the spectrum of haemorrhagic and ischaemic manifestations of
sporadic cerebral amyloid angiopathy, visible on MRI.

Andreas Charidimou et al. J Neurol Neurosurg Psychiatry
2012;83:124-137
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Why is CAA clinically relevant?
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Why CAA as disease target
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Our Team

Neurointensivists
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Neuro ICU (C-6West)
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